Pharma US ad spend fell 18.4% in '08, says Nielsen

Share this article:
Pharmaceutical industry ad spend fell 18.4% in 2008 to $4.3 billion in the US, according to The Nielsen Company. Johnson & Johnson, the sole drug company among the nation's top 10 advertisers, spent $1.2 billion on advertising – a drop of 5.4% from 2007 spend.

Overall, US ad spend declined 2.6% for the year to $136 billion, and the top 10 advertisers collectively spent 15% less than in 2007. Of the top 10 advertising sectors, the drug industry, ranked second in spending, posted the largest drop in spend, followed by the top-spending automotive industry's 15.5% cutback and an 11.4% drop in ad spend for motion pictures. Fast food was the only segment to boost spending, by 3.8%. Wal-Mart, the 19th biggest spending company, upped its advertising by a whopping 55%.

Proctor & Gamble remains the nation's top advertiser, despite having spent 19.3% less in 2008, Nielsen said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...